Annual non current assets:
$978.14M-$8.71M(-0.88%)Summary
- As of today (June 22, 2025), HALO annual long term assets is $978.14 million, with the most recent change of -$8.71 million (-0.88%) on December 31, 2024.
- During the last 3 years, HALO annual non current assets has risen by +$800.00 million (+449.08%).
- HALO annual non current assets is now -11.28% below its all-time high of $1.10 billion, reached on December 31, 2022.
Performance
HALO Non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly non current assets:
$934.50M-$43.63M(-4.46%)Summary
- As of today (June 22, 2025), HALO quarterly long term assets is $934.50 million, with the most recent change of -$43.63 million (-4.46%) on March 31, 2025.
- Over the past year, HALO quarterly non current assets has dropped by -$33.44 million (-3.45%).
- HALO quarterly non current assets is now -24.60% below its all-time high of $1.24 billion, reached on June 30, 2022.
Performance
HALO quarterly non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Non current assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
HALO Non current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | -3.5% |
| 3 y3 years | +449.1% | +438.4% |
| 5 y5 years | +4259.3% | +3732.8% |
HALO Non current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.3% | +449.1% | -24.6% | +438.4% |
| 5 y | 5-year | -11.3% | +4259.3% | -24.6% | +3732.8% |
| alltime | all time | -11.3% | >+9999.0% | -24.6% | >+9999.0% |
HALO Non current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $934.50M(-4.5%) |
| Dec 2024 | $1.09B(+45.4%) | $978.14M(-1.3%) |
| Sep 2024 | - | $991.05M(+1.0%) |
| Jun 2024 | - | $981.66M(+1.4%) |
| Mar 2024 | - | $967.94M(-1.9%) |
| Dec 2023 | $746.42M(+1.0%) | $986.85M(-2.6%) |
| Sep 2023 | - | $1.01B(-3.0%) |
| Jun 2023 | - | $1.04B(-3.7%) |
| Mar 2023 | - | $1.08B(-1.6%) |
| Dec 2022 | $739.01M(-20.2%) | $1.10B(-9.0%) |
| Sep 2022 | - | $1.21B(-2.3%) |
| Jun 2022 | - | $1.24B(+614.1%) |
| Mar 2022 | - | $173.56M(-2.6%) |
| Dec 2021 | $926.29M(+67.0%) | $178.14M(+6.0%) |
| Sep 2021 | - | $168.12M(+543.8%) |
| Jun 2021 | - | $26.11M(+5.0%) |
| Mar 2021 | - | $24.86M(-1.2%) |
| Dec 2020 | $554.76M(+2.1%) | $25.16M(+0.1%) |
| Sep 2020 | - | $25.13M(-5.6%) |
| Jun 2020 | - | $26.64M(+9.3%) |
| Mar 2020 | - | $24.38M(+8.7%) |
| Dec 2019 | $543.44M(+27.0%) | $22.44M(-20.8%) |
| Sep 2019 | - | $28.32M(+8.4%) |
| Jun 2019 | - | $26.12M(+30.1%) |
| Mar 2019 | - | $20.07M(+61.9%) |
| Dec 2018 | $427.85M(-16.2%) | $12.40M(-15.0%) |
| Sep 2018 | - | $14.58M(+14.6%) |
| Jun 2018 | - | $12.72M(+15.7%) |
| Mar 2018 | - | $11.00M(+14.9%) |
| Dec 2017 | $510.37M(+99.0%) | $9.57M(+151.7%) |
| Sep 2017 | - | $3.80M(-3.7%) |
| Jun 2017 | - | $3.95M(-10.4%) |
| Mar 2017 | - | $4.41M(-11.4%) |
| Dec 2016 | $256.53M(+49.3%) | $4.98M(-49.6%) |
| Sep 2016 | - | $9.89M(-16.0%) |
| Jun 2016 | - | $11.78M(-2.3%) |
| Mar 2016 | - | $12.06M(+20.4%) |
| Dec 2015 | $171.77M(+6.5%) | $10.02M(+77.5%) |
| Sep 2015 | - | $5.64M(+0.7%) |
| Jun 2015 | - | $5.61M(-3.3%) |
| Mar 2015 | - | $5.80M(+24.5%) |
| Dec 2014 | $161.32M(+69.5%) | $4.66M(-22.7%) |
| Sep 2014 | - | $6.03M(-6.3%) |
| Jun 2014 | - | $6.43M(-5.1%) |
| Mar 2014 | - | $6.77M(+2.7%) |
| Dec 2013 | $95.19M | $6.60M(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $7.33M(+5.2%) |
| Jun 2013 | - | $6.97M(+21.0%) |
| Mar 2013 | - | $5.76M(+40.4%) |
| Dec 2012 | $130.63M(+104.1%) | $4.10M(+73.5%) |
| Sep 2012 | - | $2.36M(+17.2%) |
| Jun 2012 | - | $2.02M(-6.3%) |
| Mar 2012 | - | $2.15M(+21.6%) |
| Dec 2011 | $63.99M(-28.5%) | $1.77M(+38.9%) |
| Sep 2011 | - | $1.27M(-14.8%) |
| Jun 2011 | - | $1.50M(-14.1%) |
| Mar 2011 | - | $1.74M(-5.7%) |
| Dec 2010 | $89.50M(+20.2%) | $1.85M(-5.8%) |
| Sep 2010 | - | $1.96M(-9.3%) |
| Jun 2010 | - | $2.16M(-13.1%) |
| Mar 2010 | - | $2.49M(-8.2%) |
| Dec 2009 | $74.44M(+0.6%) | $2.71M(+0.2%) |
| Sep 2009 | - | $2.70M(+2.1%) |
| Jun 2009 | - | $2.65M(-3.6%) |
| Mar 2009 | - | $2.75M(+7.7%) |
| Dec 2008 | $74.01M(-26.8%) | $2.55M(+1.0%) |
| Sep 2008 | - | $2.52M(+3.4%) |
| Jun 2008 | - | $2.44M(+8.4%) |
| Mar 2008 | - | $2.25M(-1.4%) |
| Dec 2007 | $101.18M(+121.9%) | $2.28M(+19.1%) |
| Sep 2007 | - | $1.92M(+62.1%) |
| Jun 2007 | - | $1.18M(+106.8%) |
| Mar 2007 | - | $572.00K(+14.9%) |
| Dec 2006 | $45.59M(+126.8%) | $497.80K(+3.8%) |
| Sep 2006 | - | $479.70K(+23.5%) |
| Jun 2006 | - | $388.30K(-0.4%) |
| Mar 2006 | - | $390.00K(-3.5%) |
| Dec 2005 | $20.11M(+24.5%) | $404.10K(-9.8%) |
| Sep 2005 | - | $448.00K(+14.3%) |
| Jun 2005 | - | $392.00K(+16.5%) |
| Mar 2005 | - | $336.40K(+30.4%) |
| Dec 2004 | $16.15M(+3106.0%) | $258.00K(+47.9%) |
| Sep 2004 | - | $174.40K(-3.5%) |
| Jun 2004 | - | $180.80K(+10.3%) |
| Mar 2004 | - | $163.90K(+6456.0%) |
| Dec 2003 | $503.60K(+1829.5%) | - |
| Sep 2003 | - | $2500.00(-44.4%) |
| Jun 2003 | - | $4500.00(>+9900.0%) |
| Mar 2003 | - | $0.00(-100.0%) |
| Sep 2002 | - | $25.00K(0.0%) |
| Jun 2002 | - | $25.00K(>+9900.0%) |
| Mar 2002 | - | $0.00 |
| Dec 2001 | $26.10K | - |
FAQ
- What is Halozyme Therapeutics annual long term assets?
- What is the all time high annual non current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual non current assets year-on-year change?
- What is Halozyme Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly non current assets year-on-year change?
What is Halozyme Therapeutics annual long term assets?
The current annual non current assets of HALO is $978.14M
What is the all time high annual non current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual long term assets is $1.10B
What is Halozyme Therapeutics annual non current assets year-on-year change?
Over the past year, HALO annual long term assets has changed by -$8.71M (-0.88%)
What is Halozyme Therapeutics quarterly long term assets?
The current quarterly non current assets of HALO is $934.50M
What is the all time high quarterly non current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly long term assets is $1.24B
What is Halozyme Therapeutics quarterly non current assets year-on-year change?
Over the past year, HALO quarterly long term assets has changed by -$33.44M (-3.45%)